drugset / Trial / NCT00435461

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

NCT00435461

Phase 4 Completed 1000 enrolled GlaxoSmithKline
RandomizedParallel-groupTreatment

Summary

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

Timeline

Start
2006-12-20
Primary completion
2007-02-01
Completion
2007-02-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown
Subject Fluticasone Furoate Other / unclassified